At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

Nuo Therapeutics, Inc. (OTCQB: AURX) ("Nuo"), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging ...

Detailed price information for Smith & Nephew Snats ADR (SNN-N) from The Globe and Mail including charting and trades.

Smith+Nephew (NYSE: SNN) reported first-quarter results that fell in line with sales expectations on Wall Street.

Under the Agreement, Smith+Nephew will market and sell CENTRIO Platelet-Rich Plasma System, their own branded version of Nuo’s underlying Aurix® System to the United States wound care market.

UK medical products maker Smith+Nephew beat first-quarter revenue growth expectations and maintained its full-year sales and profit margin forecasts on Wednesday, despite the potential impact of U.S.

The U.S. Advanced Wound Care market has demonstrated strong growth, with its valuation at $3.35 billion in 2019, and projections suggest it will reach $4.97 billion by 2027. This ...

Major players like Smith & Nephew, 3M, and Mölnlycke are heavily investing in R&D for nanotechnology-infused dressings and next-gen antimicrobial solutions to stay ahead in this rapidly evolving ...